Loading organizations...
§ Private Profile · Cardiff By The Sea, CA, USA
Precision oncology targeting virus-associated malignancies.
Viracta Therapeutics has raised $143.4M across 4 funding rounds.
Viracta Therapeutics has raised $143.4M in total across 4 funding rounds.
Viracta Therapeutics has raised $143.4M across 4 funding rounds. Most recently, it raised $50.0M Debt in November 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 5, 2021 | $50M Debt Financing | Oxford Finance, Silicon Valley Bank | — | Announced |
| Feb 24, 2021 | $65M Venture Round | — | — | Announced |
| Dec 4, 2018 | $10M Venture Round | Kevin YE | Forward Ventures, Latterell Venture Partners, NantKwest, VI Ventures | Announced |
| Apr 6, 2017 | $18.4M Series B | Patrick Soon Shiong | Forward Ventures, Latterell Venture Partners, Wicklow Capital | Announced |
Viracta Therapeutics has raised $143.4M in total across 4 funding rounds.
Viracta Therapeutics's investors include Oxford Finance, Silicon Valley Bank, Kevin Ye, Forward Ventures, Latterell Venture Partners, NantKwest, VI Ventures, Patrick Soon-Shiong, Wicklow Capital.